Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Sensitivity and Specificity of a Novel Quality of Life (QoL) Tool to Assess the Treatment Satisfaction in Psoriasis Patients

NCT04765332 is registered in ClinicalTrials.gov with Clinact as lead sponsor.

NCT NCT04765332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04765332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Sensitivity and Specificity of a Novel Quality of Life (QoL) Tool to Assess the Treatment Satisfaction in Psoriasis Patients
Lead sponsor
Clinact
Phase
Observational
Overall status
Completed
Start date
December 4, 2020
Completion date
March 13, 2023
Enrollment
143 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis